Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 113 of 144 pages ‹ First < 111 112 113 114 115 > Last ›
HSL16363
Wilkinson JJ, Force RW, Cady PS.
Impact of safety warnings on drug utilization: marketplace life span of cisapride and troglitazone.
Pharmacotherapy 2004 Aug; 24:(8):978-86
http://www.ncbi.nlm.nih.gov/pubmed/15338846
HSL20294
Margolis C, Jotkowitz A, Sitter H.
A problem solving and decision making toolbox for approaching clinical problems and decisions.
Inflamm Res 2004 Aug; 53:
http://www.ncbi.nlm.nih.gov/pubmed/15338073
HSL19968
Robotham J
Drug maker accused of scare-mongering
The Sydney Morning Herald 2004 July 31
http://www.smh.com.au/small-business/drug-maker-accused-of-scaremongering-20090619-cpta.html
HSL19846
Rouse R
Call for GP use of drug samples to be reviewed
Medical Observer 2004 July 305
HSL506
California Pharmacies Sue Drug Makers, Allege Price Fixing
The Wall Street Journal 2004 Jul 26
HSL20029
McCrory G
Super Bribe Me now showing
Australian Doctor 2004 July 23 31
HSL495
Morais R.
Prozac Nation? Is the Party Over?
FORBES.com 2004 Jul 20
HSL121
Roehr B.
Stronger sanctions needed against companies that suppress data.
BMJ 2004 Jul 17; 329:(7458):132
http://bmj.bmjjournals.com/cgi/content/full/329/7458/132
HSL1777
Centers for Disease Control and Prevention (CDC).
Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.
MMWR Morb Mortal Wkly Rep 2004 Jul 16; 53:(27):603-6
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5327a1.htm
HSL1687
MacKinnon NJ.
Use of drug samples as a threat to seamless health care.
Am J Health Syst Pharm 2004 Jul 15; 61:(14):1497-500
http://www.ajhp.org/cgi/reprint/61/14/1497.pdf
HSL122
Lenzer J.
Whistleblower charges medical oversight bureau with corruption.
BMJ 2004 Jul 10; 329:(7457):69
http://bmj.bmjjournals.com/cgi/content/full/329/7457/69
HSL123
Herxheimer A.
Open access to industry's clinically relevant data: Urgently needed but when will we get it, and in what form
BMJ 2004 Jul 10; 329:(7457):64-5
http://bmj.bmjjournals.com/cgi/content/full/329/7457/64
HSL4472
Henson L.
Ego overload.
Australian Doctor Weekly 2004 Jul 5
HSL19791
Charatan F
Drug marketing practices come under scrunity
BMJ 2004 July 3; 329:(10):2
http://www.bmj.com/content/329/7456/10.2.full
HSL19792
Hopkins Tanne J
National Institutes of Health criticised for not preventing conflicts of interest
BMJ 2004 July 3; 329:(7456):10
http://www.bmj.com/content/329/7456/10.2.full
HSL18035
Eaton L
GPs asked not to dmand payments from drg company representatives
BMJ 2004 July 1; 329:(7457):72
http://www.bmj.com/cgi/content/full/329/7457/72-d
HSL2411
Daikos GK.
Ethical dilemmas encountered during clinical drug trials.
Int J Antimicrob Agents 2004 Jul; 24:(1):24-31
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T7H-4CMHWSF-2&_coverDate=07%2F31%2F2004&_alid=309771980&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5059&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=a39ea5f611120e36cb595ba331e785fc
HSL2412
Romero CE, Baron JD, Knox AP, Hinchey JA, Ropper AH.
Barbiturate withdrawal following Internet purchase of Fioricet.
Arch Neurol 2004 Jul; 61:(7):1111-2
http://archneur.ama-assn.org/cgi/content/full/61/7/1111
HSL2413
Frankenberger KA, Frankenberger WR, Peden BF, Hunt HL, Raschick CM, Steller EG, Peterson JA.
Effects of information on college students' perceptions of antidepressant medication.
J Am Coll Health 2004 Jul-Aug; 53:(1):35-40
HSL4814
Pai SA.
Publication ethics policies for medical journals.
Indian J Med Ethics 2004 Jul-Sep; 1:(3):93
HSL4815
Kamtekar R.
Why life-saving drugs should be public goals.
Indian J Med Ethics 2004 Jul-Sep; 1:(3):77-8
HSL19389
Manchanda P, Chintagunta P
Responsiveness of physician prescription behaviour to salesforce effort: an individual level analysis
Market Lett 2004 July; 15:(2):129-145
http://ideas.repec.org/a/kap/mktlet/v15y2004i2_3p129-145.html
HSL461
Reputations of Pharmaceutical and Health Insurance Companies Continue Their Downward Slide June 22, 2004
2004 Jun 30
HSL471
Letter to the Editor
Washington Post 2004 Jun 30
HSL472
Editorial: Missing Drug Data
The Washington Post 2004 Jun 30
HSL473
Evans R.
FoE joy as Bayer drops legal action
The Guardian 2004 Jun 30
HSL474
Pear R.
Investigators Say Drug Makers Repeatedly Overcharged
The New York Times 2004 Jun 30
HSL475
Hensley S.
Drug Firms Address Furor on Tests: New Guidance on Results Aims to Calm Concerns Over Negative Trial Data
The Wall Street Journal 2004 Jun 30
HSL476
Meier B.
Forest Asked to Supply Information on Marketing of Some Drugs
The New York Times 2004 Jun 30
HSL470
Wysocki B.
At Pitt, Scientists Decode The Secret of Getting Grants
The Wall Street Journal 2004 Jun 28
HSL459
Goozner M.
From The $800 Million Pill - Me Too!
Medscape 2004 Jun 27
HSL469
Fonda D.
Curbing The Drug Marketers - How a clampdown on pitching drugs for unapproved uses is changing the way Big Pharma operates
Time 2004 Jun 27
HSL215
Dodge , C .
Most U.S. Seniors Don't Know Medicare Bill Passed, Survey Shows
Bloomberg News 2004 Jun 26
HSL468
Meier B.
Drug Maker Acknowledges Some Negative Test Results
The New York Times 2004 Jun 26
HSL16749
Wolfe SM.
Dangers of rosuvastatin identified before and after FDA approval.
Lancet 2004 Jun 26; 363:(9427):2189-90
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(04)16513-6
HSL466
Martinez B.
Big U.S. firms could reap windfall
The Globe and Mail 2004 Jun 25
HSL467
Whiting R.
Drugmakers Respond To Calls For Public Database Of Trials
InformationWeek 2004 Jun 25
HSL464
Metherell M.
Experts haggling over drug listing secrecy
Sydney Morning Hearld 2004 Jun 24
HSL465
PBS: where the real threat is
Sydney Morning Hearld 2004 Jun 24
HSL462
McGrath C.
Labor feels the heat over PBS backflip
The ABC 2004 Jun 23
HSL463
Meier B
Democrats Take a Look at Drug Tests
The New York Times 2004 Jun 23
HSL781
Bazell R.
Why are the new cancer drugs so expensive?
NBC News 2004 Jun 23
HSL458
Fox M.
Health Agency Proposes Ethics Crackdown
Reuters 2004 Jun 22
HSL460
Testimony to the Ways and Means Committee, U.S. House of Representatives US-Australia Free Trade Agreement: Implications for Prescription Drug Prices in the US and Australia
2004 Jun 22
HSL454
Frenkel J.
Clampdown on chemists to save $8b
The Herald Sun 2004 Jun 21
HSL455
Tragic teen suicides inspire idea that invites more
USA Today 2004 Jun 21
HSL456
Meier B.
A Medical Journal Quandary: How to Report on Drug Trials
The New York Times 2004 Jun 21
HSL457
Tuller D
Gentlemen, Start Your Engines?
T he New York Times 2004 Jun 21
HSL450
Dr. Kate
It's time to focus on information bias about drugs
Times Star 2004 Jun 20
HSL451
Scannel K.
It's time to focus on information bias about drugs
Times Star 2004 Jun 20
HSL452
Gardiner H.
Antidepressants Restudied for Relation to Child Suicide
The New York Times 2004 Jun 20
HSL453
Hassner V.
Sharav Drugs' risks too great
USA Today 2004 Jun 20
HSL448
Inquiry into pharmaceutical industry a victory for consumer rights
Mind Chief Executive 2004 Jun 18
HSL449
New Inquiry - Terms of Reference: The Influence of the Pharmaceutical Industry
2004 Jun 18
HSL446
How to Find the Latest On Results of Clinical Trials As Groups Debate Access To Research, Existing Sources Of Information Are Growing
Wall Street Journal 2004 Jun 17
HSL447
Senator Says FDA Put Pressure On Staffer Over Antidepressants
The Wall Street Journal 2004 Jun 17
HSL8149
Zaneski CT.
Medical sales reps arrive bearing gifts
Baltimore Sun 2004 Jun 17
http://pqasb.pqarchiver.com/baltsun/access/652026571.html?dids=652026571:652026571&FMT=ABS&FMTS=ABS:FT&date=Jun+17%2C+2004&author=Cyril+T.+Zaneski&pub=The+Sun&desc=Medical+sales+reps+arrive+bearing+gifts+
HSL19738
Shah J
Criteria influencing the clinical uptake of pharmacogenomic strategies
BMJ 2004 Jun 17; 328:
http://www.bmj.com/content/328/7454/1482
HSL20233
Cialdini RB
Doctors are not scientists
BMJ 2004 Jun 17; 328:
http://www.bmj.com/content/328/7454/0.9.full
HSL444
Whalen J.
Glaxo Releases Studies on Drug For Depression
The Wall Street Journal 2004 Jun 16
HSL445
AMA Supports Public Registry For Clinical Trials, Outcomes
The Wall Street Journal 2004 Jun 16
HSL4473
Efrat Z.
Under the influence
Australian Doctor Weekly 2004 Jun 16
HSL440
Gordon J, Wroe D.
PBS need not cost more: Labor
The Age 2004 Jun 15
HSL441
Fabro A.
FTA study claims drug costs will rise
Australian Financial Review 2004 Jun 15
HSL442
Meier B.
Group Weighs Plan for Full Drug-Trial Disclosure
The New York Times 2004 Jun 15
HSL443
AMA turns down proposal to ease guideline on gifts Doctor says policy ignored by many
Associated Press 2004 Jun 15
HSL2410
Grup d'Etica Societat Catalana de Medicina Familiar i Comunitaria.
[Ethics in drug industry relations.
Opinions poll of family physicians in Catalonia]Aten Primaria 2004 Jun 15; 34:(1):6-12
http://www.elsevier.es/sites/default/files/elsevier/pdf/27/27v34n01a13062819pdf001.pdf
HSL439
Condie .
Glaxo dismisses free trade concerns
Evening Standard 2004 Jun 14
HSL438
Cornacchia C.
Drugs: They don't Want to Go
There Monteal Gazette 2004 Jun 13
HSL435
Bad medicine
The Guardian 2004 Jun 12
HSL436
Yallop R.
Use it and lose it: end looms for antibiotics era
The Australian 2004 Jun 12
HSL19510
Dealing in drugs
The Lancet 2004 Jun 11; 364:(9446):1655-1656
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736%2804%2917375-3
HSL19808
Dyer O
GlaxoSmithKline faces US lawsuit over concealment of trial results
BMJ 2004 Jun 10; 328:(7453):1395
http://www.bmj.com/content/328/7453/1395.1.full.pdf
HSL433
Burling S.
Getting the bad news with the good news about a drug: The AMA may ask Health and Human Services to create a registry of all clinical trials and their results.
The Philadelphia Inquirer 2004 Jun 9
HSL434
Nearly a Quarter of Canadians Report a Preventable Adverse Event in Own Care or That of a Family Member: Fifth annual report showcases advances in patient safety and key health trends
The Canadian Institute for Health Information 2004 Jun 9
HSL432
Marre K.
PhRMA, Chamber team up to reduce worker depression
The Hill 2004 Jun 8
HSL430
Garnier comes out fighting
The Telegraph 2004 Jun 6
HSL431
Bischoff A.
Silence and Suicide
2004 Jun 6
HSL1269
Hallam K.
U.S. Senators Agree on Bill to Speed Generic Drugs to Market
Bloomberg News 2004 Jun 5
http://www.bloomberg.com/apps/news?pid=10000103&sid=a8gdDWSCHy4M&refer=us
HSL426
Eyers J.
PBS politics 'a risk to R&D'
Financial Review 2004 Jun 4
HSL427
Weiss L, Thurbon E.
The FTA: pandering to Rome
Financial Review 2004 Jun 4
HSL1161
Toop L, Richards D.
Physicians' negative views of direct-to-consumer advertising (DTCA): the international evidence grows.
N Z Med J 2004 Jun 4; 117:(1195):U905
HSL1163
Toivianen H, Vuorenkoski L, Hemminki E.
Finnish physicians show little support for consumer advertising of prescription drugs.
N Z Med J 2004 Jun 4; 117:(1195):U907
HSL424
Bosley S.
We're losing the malaria battle
The Guardian 2004 Jun 3
HSL425
Meier B.
Two Studies, Two Results, and a Debate Over a Drug
The New York Times 2004 Jun 3
HSL20387
Rodwin MA
Financial incentives for doctors
BMJ 2004 Jun 3; 328:(1328):
http://www.bmj.com/content/328/7452/1328
HSL477
Davidson K
Why rush a free trade deal, Mr Howard?
The Age 2004 Jun 1
HSL478
Press Release: Tangled Patent Linkages Reduce Stimulation for Pharmaceutical Innovation 6,730 patents for only 27 pharmaceutical inventions
European Generic Medicines Assocation 2004 Jun 1
HSL1784
Bojo Canales C, Carabantes Alarcon D, Veiga de Cabo J, Martinez Hernandez D.
[Bibliometric analysis of the Spanish Journal of Chemotherapy (1996-2000)]
Rev Esp Quimioterap 2004 Jun 01; 17:(2):161-8
http://www.seq.es/seq/0214-3429/17/2/161.pdf
HSL2402
Fabius AM, Cheung KC, Rijcken CJ, Vinkers CH, Talsma H.
Direct-to-consumer communication on prescription only medicines via the internet in the Netherlands, a pilot study. Opinion of the pharmaceutical industry, patient associations and support groups.
Pharm World Sci. 2004 Jun;26(3):169-72. 2004 Jun 01; 26:(3):169-72
http://www.springerlink.com/app/home/contribution.asp?wasp=98360afffdd6456eb349cd696958a670&referrer=parent&backto=issue,11,14;journal,7,51;linkingpublicationresults,1:102977,1
HSL20193
Breitstein J
DTC's next chapter
Pharmaceutical Executive 2004 Jun 1
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=98288
HSL1778
Caudill-Slosberg MA, Schwartz LM, Woloshin S.
Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs 2000.
Pain 2004 Jun; 109:(3):514-9
http://linkinghub.elsevier.com/retrieve/pii/S0304395904001307
HSL2403
Iijima H, Kamei M, Koshimizu T, Shiragami M.
Objective evaluation of generic drug information.
Yakugaku Zasshi 2004 Jun; 124:(6):341-7
http://www.jstage.jst.go.jp/article/yakushi/124/6/124_341/_article
HSL2404
Lofgren H, Boer R.
Pharmaceuticals in Australia: developments in regulation and governance.
Soc Sci Med 2004 Jun; 58:(12):2397-407
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-49TRJNX-3&_coverDate=06%2F30%2F2004&_alid=309687084&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5925&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=263c064a195f0e23b51bbc91dc7b8f47
HSL9672
Mark TL, Swait J.
Using stated preference and revealed preference modeling to evaluate prescribing decisions.
Health Econ 2004 Jun; 13:(6):563-73
HSL9681
Griffin MR, Stein CM, Ray WA.
Postmarketing surveillance for drug safety: surely we can do better.
Clin Pharmacol Ther 2004 Jun; 75:(6):491-4
http://www.nature.com/clpt/journal/v75/n6/abs/clpt2004437a.html;jsessionid=6BA333DB9D150894CD998F5ACAF3F92C
HSL9683
Cha R, Sobel JD.
Fluconazole for the treatment of candidiasis: 15 years experience.
Expert Rev Anti Infect Ther 2004 Jun; 2:(3):357-66
HSL9694
Rutter PM, Horsley E, Brown DT.
Evaluation of community pharmacists' recommendations to standardized patient scenarios.
Ann Pharmacother 2004 Jun; 38:(6):1080-5
http://www.theannals.com/cgi/content/full/38/6/1080
HSL1795
Snapinn S, Cook T, Shapiro D, Snavely D.
The role of the unblinded sponsor statistician.
Stat Med 2004 May 30; 23:(10):1531-3
http://www3.interscience.wiley.com/cgi-bin/abstract/108561305/ABSTRACT
HSL2401
Lachin JM.
Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
Stat Med 2004 May 30; 23:(10):1519-21
http://www3.interscience.wiley.com/cgi-bin/abstract/108561304/ABSTRACT
Page 113 of 144 pages ‹ First < 111 112 113 114 115 > Last ›
